Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CDK17 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | LLGL2 | CCLE | pan-cancer | AAC | 0.21 | 0.0006 |
mRNA | HBB | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | MAP3K9 | CCLE | pan-cancer | AAC | 0.18 | 0.0006 |
mRNA | MAN1A2 | FIMM | pan-cancer | AAC | 0.61 | 0.0006 |
mRNA | GJB5 | CCLE | pan-cancer | AAC | 0.19 | 0.0006 |
mRNA | FAM45A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | TNKS1BP1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
mRNA | RARRES3 | CCLE | pan-cancer | AAC | 0.17 | 0.0006 |
mRNA | HSBP1 | CCLE | pan-cancer | AAC | -0.17 | 0.0006 |